Thomas Illmer

11.4k citations

101 papers · 5.2k indexed · 2 hit papers · h-index 32

Impact in

Hematology top 0.2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
Genetics top 0.5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research

Papers in

Hematology 62
- Acute Myeloid Leukemia Research 41
- Chronic Myeloid Leukemia Treatments 26
- Hematopoietic Stem Cell Transplantation 15
Genetics 31
- Chronic Lymphocytic Leukemia Research 17
- Myeloproliferative Neoplasms: Diagnosis and Treatment 6

Co-authors: Gerhard Ehninger Markus Schaich Christian Thiede Martin Bornhäuser Christine Steudel Ulrike Schäkel Uwe Platzbecker Brigitte Mohr
Journals: Blood (23 papers)Journal of Clinical Oncology (7 papers)Bone Marrow Transplantation (6 papers)Leukemia (5 papers)British Journal of Haematology (4 papers)
Partner nations: Germany United States Austria

In The Last Decade

Thomas Illmer

97 papers receiving 5.1k citations

Hit Papers

align trajectories log scale

Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML) 2006 · 509 citations

Peers

Countries citing papers authored by Thomas Illmer

Since Specialization

Citations

This map shows the geographic impact of Thomas Illmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Illmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Illmer more than expected).

Fields of papers citing papers by Thomas Illmer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Illmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Illmer. The network helps show where Thomas Illmer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Thomas Illmer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Illmer Line = papers co-authored together Thomas Illmer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	1328MO Hypofractionated radiotherapy of single tumor lesion increases systemic response rate to pembrolizumab in recurrent or metastatic head-and-neck cancer (R/M-HNSCC): Primary endpoint of the randomized Keynote-717 trial Annals of Oncology ·Nicole Hollander, Bálint Tamaskovics, M. Yamin, W. Budach, Thomas Illmer, J. Radke, Oliver Koelbl, А. В. Косарева, Patrick Melchior, T Evans, Claus Rödel, P Lemburg, 阿部和久, Anke Reinacher‐Schick, Axel Hinke, Axel Kallies, Ke Zhan, Benjamin Frey, 杨希 Yang Xi, J. Montillier	2025	0
2	944TiP Randomized phase II study of immune stimulation with pembrolizumab and radiotherapy of recurrent and/or metastatic head and neck squamous cell carcinoma : The IMPORTANCE trial Annals of Oncology ·Bálint Tamaskovics, Markus Hecht, Philipp Schubert, Axel Kallies, Thomas Illmer, J. Radke, Oliver Koelbl, Felix Steger, Thomas Brunner, Claus Rödel, Maximilian Fleischmann, Anke Reinacher‐Schick, Minjain Cui, Patrick Melchior, Günther Klautke, Raquel M Rodriguez, Udo S. Gaipl, Jan Haussmann, Wilfried Budach, Rainer Fietkau	2023	1
3	2022-RA-672-ESGO Comparison of quality of life in patients with platinum-sensitive recurrent ovarian, fallopian tube and peritoneal cancer treated with trabectedin plus pegylated liposomal doxorubicin (PLD) or standard platinum-based therapy: Data look of the NOGGO S16/COMPASS trial International Journal of Gynecological Cancer ·Radoslav Chekerov, Mustafa Deryal, Bahriye Aktas, Robert Röhle, Nelson A. Wells, Marco Johannes Battista, Christian M. Kurbacher, Pauline Wimberger, Saurabh S. Pardeshi, Jana Barinoff, 正子永井, 王晓芳, Maximilian Klar, 张茂泽, 知也舘, Gülten Oskay-Özcelik, Thomas Illmer, Thorsten Oliver Götze, Klaus Pietzner, Jalid Sehouli	2022	1
4	Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression Haematologica ·John F. Seymour, Robert Marcus, Andrew Davies, Eve Gallop‐Evans, Madeline R. Buerle, Andrew Haynes, Michael Herold, Thomas Illmer, Herman Nilsson‐Ehle, Martin Sökler, Sabina Shahin, Tina Nielsen, Aino Launonen, Wolfgang Hiddemann	2018	69
5	MiR-134-mediated β1 integrin expression and function in mesenchymal stem cells Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·David M. Poitz, Friedrich Stölzel, Quentin Rioual, Jens Friedrichs, Denitsa Docheva, Matthias Schieker, Fernando A. Fierro, Uwe Platzbecker, Rainer Ordemann, Carsten Werner, Martin Bornhäuser, Ruth H. Strasser, Gerhard Ehninger, Thomas Illmer	2013	17
6	Clonal Evolution Including Partial Loss of Human Leukocyte Antigen Genes Favoring Extramedullary Acute Myeloid Leukemia Relapse After Matched Related Allogeneic Hematopoietic Stem Cell Transplantation Transplantation ·Friedrich Stölzel, Karl Hackmann, Beatrice Gruendler, Brigitte Mohr, Monika Füssel, Uta Oelschlägel, Christian Thiede, Christoph Röllig, Uwe Platzbecker, Johannes Schetelig, Thomas Illmer, Markus Schaich, Barbara Seliger, Arndt Hartmann, Gustavo Baretton, Christian Zietz, Gerhard Ehninger, Evelin Schröck, Martin Bornhäuser	2012	37
7	Posaconazole prophylaxis during induction therapy of patients with acute lymphoblastic leukaemia Mycoses ·Thomas Illmer, Jana Babatz, Stefan Pursche, Friedrich Stölzel, Ulrich S. Schuler, Markus Schaich, Gerhard Ehninger	2010	8
8	A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients Annals of Oncology ·Markus Schaich, Katherine Gabriela Guanga Gualan, Markus Pfirrmann, Katja Robel, Thomas Illmer, Michael Krämer, 丁晓医, Gerhard Ehninger, Gabriele Schackert, Dietmar Krex	2008	111
9	Targeting mycophenolate mofetil for graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation Bone Marrow Transplantation ·Pedro T. Cortés González, Jens Freiberg‐Richter, Uwe Platzbecker, Alexander Kiani, Johannes Schetelig, Thomas Illmer, Gerhard Ehninger, Eberhard Schleyer, Martin Bornhäuser	2008	31
10	Inhibition of platelet‐derived growth factor receptorβ by imatinib mesylate suppresses proliferation and alters differentiation of human mesenchymal stem cells in vitro Cell Proliferation ·Fernando A. Fierro, Thomas Illmer, Duohui Jing, Eberhard Schleyer, Gerhard Ehninger, Sabine Boxberger, Martin Bornhäuser	2007	78
11	FLT3 Kinase Inhibitors in the Management of Acute Myeloid Leukemia Clinical Lymphoma & Myeloma ·Thomas Illmer, Gerhard Ehninger	2007	22
12	Kinetics of CXCR-4 and adhesion molecule expression during autologous stem cell mobilisation with G-CSF plus AMD3100 in patients with multiple myeloma Annals of Hematology ·Uta Oelschlaegel, Martin Bornhäuser, Sabine Boxberger, Frank Kroschinsky, Thomas Illmer, Daria Riabov Bassat, Gary Calandra, Gerhard Ehninger, Uwe Platzbecker	2007	22
13	Detection of β-herpesviruses in allogenic stem cell recipients by quantitative real-time PCR Journal of Virological Methods ·李宏光, Jacques Rohayem, Thomas Illmer, Ṭāhā J. al ‘Alwānī	2006	31
14	Fast Appearance of Donor Dendritic Cells in Human Skin: Dynamics of Skin and Blood Dendritic Cells after Allogeneic Hematopoietic Cell Transplantation Transplantation ·Susanne Auffermann-Gretzinger, Oates González, Martin Bornhäuser, Knut Schäkel, Uta Oelschlaegel, Markus Schaich, Thomas Illmer, Christian Thiede, Gerhard Ehninger	2006	33
15	Arsenic-induced APL differentiation in cerebrospinal fluid Leukemia Research ·D. Onopriichyk, Matthias Klemm, Gigih Gumelar Pangestu, Christoph Röllig, Nasstasja Wassilew, Gerhard Ehninger, Thomas Illmer	2006	13
16	ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-κB activity and AT1 receptor expression Biochemical and Biophysical Research Communications ·Alexander Schmeißer, Oliver Soehnlein, Thomas Illmer, Hanns‐Martin Lorenz, Saeed Eskafi, Ajay B. Kulkarni, Christoph Gabler, Ruth H. Strasser, Werner G. Daniel, Christoph D. Garlichs	2004	62
17	Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia Genes Chromosomes and Cancer ·Christine Steudel, Martin Wermke, Markus Schaich, Ulrike Schäkel, Thomas Illmer, Gerhard Ehninger, Christian Thiede	2003	115
18	Association of specific cytogenetic aberrations with mdr1 gene expression in adult myeloid leukemia and its implication in treatment outcome. PubMed ·Markus Schaich, E. J. Hopkins, Ulrich Pascheberg, Brigitte Mohr, Silke Soucek, Gerhard Ehninger, Thomas Illmer	2002	16
19	Double lumen port access in patients receiving allogeneic blood stem cell transplantation Bone Marrow Transplantation ·Uwe Platzbecker, Thomas Illmer, Markus Schaich, Jens Freiberg‐Richter, A Helwig, Michela Corti, Andreas Jenke, Gerhard Ehninger, Martin Bornhäuser	2001	8
20	Complex cytogenetic and immunophenotypic aberrations in a patient with Sezary syndrome Cancer Genetics and Cytogenetics ·Brigitte Mohr, Thomas Illmer, Uta Oelschlägel, А. В. Хряков, Kristina Hölig, 国聚韩, Frank Kroschinsky, Ulrich S. Schuler, Gerhard Ehninger	1996	5

About Thomas Illmer

Thomas Illmer is a scholar working on Hematology, Genetics, Oncology, Cancer Research and Immunology, having authored 101 papers that have together received 5.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (41 papers), Chronic Myeloid Leukemia Treatments (26 papers), Chronic Lymphocytic Leukemia Research (17 papers), Hematopoietic Stem Cell Transplantation (15 papers), Drug Transport and Resistance Mechanisms (8 papers), Acute Lymphoblastic Leukemia research (8 papers), Retinoids in leukemia and cellular processes (7 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers). The work is most often cited by research in Hematology (3.1k citations), Genetics (1.6k citations), Clinical Biochemistry (285 citations), Oncology (1.1k citations) and Cancer Research (464 citations). Thomas Illmer has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Gerhard Ehninger, Markus Schaich, Christian Thiede, Martin Bornhäuser, Christine Steudel, Ulrike Schäkel, Uwe Platzbecker, Brigitte Mohr, Andreas Neubauer and Martin Wermke. Their work appears in journals such as Blood, Journal of Clinical Oncology, Bone Marrow Transplantation, Leukemia and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact